About Us

SPAGO Imaging is a biotechnology company with expert capabilities in contrast agent- and nanoscale life science research.

The main focus of the company is the development of an innovative and proprietary MRI (Magnetic Resonance Imaging) contrast agent for earlier and more specific visualization of soft tissue tumors than what is possible today.

SPAGO Imaging encompasses many years of experience from contrast- and pharma industry, including discovery research, early clinical- and business development.

The company was established in 2007 and is now located in Lund, Sweden and employs a team of eight. SPAGO Imaging is a subsidiary of Accelerator Nordic AB, publicly traded on the “Aktietorget” exchange in Stockholm.